Rectal administration of methohexitone is an effective technique for the induction of anaesthesia in young children and several doses and concentrations of the drug have been used.~-6 However, when methohexitone is administered as a ten per cent solution in the usual clinical doses approximately 15 per cent of patients do not fall asleep, 3-6 This unpredictability may occur because of variation in the absorption or systemic availability of the drug. Many factors affect absorption and distribution of rectally administered medications including drug formulation, site of absorption within the rectum, and concentration and volume of the solution administered. 7's
Laishley et al. reported that rectal administration of 15 mg' kg -~ one per cent methohexitone, and 25 rag. kg -~ ten percent methohexitone, were equally effective for the induction of anaesthesia in children, but that use of 15 mg'kg -t ef a ten per cent solution resulted m a significantly higher failure rate. 9 In addition, damage to the rectal mucosa has been reported following administration of ten per cent methohexitone in mice. Lo. ~ ~ Becau se of the potential problems of failed inductions and mucosal injury that may occur with the use of ten per cent methohexitone, a more dilute solution of rectal methohexitone may be desirable for induction of anaesthesia in children. Therefore, the purpose of this investigation was to compare plasma rnethohexitone concentration, time to the onset of sleep and post-anaesthesia recovery in children following rectal administration of 25 mg'kg-1 methohexitone, as either a two or ten per cent solution.
Methods
Thirty ASA physical status I children, aged one to six years, scheduled for elective surgery were studied after obtaining informed parental consent to the institutionally approved protocol. All patients were unpremedicated and accompanied to the preoperative holding area by their parents. They were randomly assigned to receive either the two or ten per cent methohexitone solution. The solutions were prepared by dissolving 500 mg sodium methohexitone in 5 or 25 m l of sterile water to form the ten and two per cent solutions, respectively, fiach child received a total dose of 25 mg" kg -~ .
The drug was instilled through a serf, plastic catheter inserted approximately 3 cm into the rectum, while the patient was held and comforted by a parent. The time from administration of the drug until the onset of sleep was recorded. For purposes of this investigation sleep was defined as loss of consciousness, unresponsiveness In verbal stimuli, and absence of voluntary movement when unstimulated.
Children were then transported to the operating room, intravenous cannulation performed and anaesthesia con-tinued with nitrous oxide and halothane in oxygen, except in a single patient with a family history of malignant hyperthermia in whom nitrous oxide and fentanyl were used. Blood samples (1-2 ml) for determination of methohexitone concentration in plasma were collected from a peripheral vein at 15, 30, ';5 and i20 minutes following administration of the rectal me~hohexitone. The samples were centrifuged and the plasma frozen for later assay using gas chromatography.
Following completion of surgery, anaesthesia was discontinued and the children were taken to the recovery room to awaken in the presence of their parents. Recovery time was noted and recovery assessed by a blinded observer using Steward's postanaesthesia recovery score t2 which assigns points based upon the level of consciousness, the ability to maintain a patent airway and patient movement. The maximum score is six and indicates that the child is awake, capable of crying or coughing and moving purposefully. Scores for each patient were determined upon admission to the recovery room, at 5, I5, 30 and 60 minutes following admission, and at the time the child was discharged from the recovery room.
Methohexitone concentrations were determined using the technique described by Van Hamme and Ghoneim. ~3 After extraction of methohexitonr from plasma samples with hexane, hexobarbitone was added as an internal control and separation of the sample performed on a Hewlett Packard 5830A gas chromatograph. The area of the curves was measured on a Hewlett Packard integrator and n~ethohexitone concentrations calculated l~om a calibration graph derived from control plasma to which known amounts of drug had been added. Using this method of extraction the correlation coefficient of control plasma containing known amounts of methohexitone was linear for concentrations between 0.1-20 Ixg" ml -I (r = 0.99). Sensitivity of the assay was 0.03 ~g-ml -l and reproducibility of duplicate samples =8 per cent.
Results are expressed as mean +_ SD_ Induction and recovery times and plasma methohexitone concentrations were analyzed using Student's t test with p < 0.05 considered significant. The recovery room scores were analyzed using the Wilcoxon non-paired rank sum test. The plasma methohexitone concentrations at 15, 30 and 45 minutes were significantly higher following administration of the two per cent solution (Figure 2 ). In the four patients that did not fall asleep the 15-minute plasma samples were not obtained. Initial samples from these patients were collected 21-30 minutes after administration of the rectal methohexitone and following induction of anaesthesia with halothane, nitrous oxide and oxygen. Peak plasma concentrations in these four patients ranged from 0.31-1.71 ~g-ml -t immediately after the induction of anaesthesia.
Postanaesthesia recovery was similar in the two groups. Time from discontinuing anaesthesia until discharge from the recovery room was 88 -27 minutes and
Results
The two groups of children were comparable in age, weight, methohexitone dose administered and duration of Age (months) surgery (Table) . Following rectal administration of methosex Male hexitone, 26 of 30 patients fell asleep within ! 5 minutes. Female Four patients, although sedated, remained awake [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Weight (kg) minutes after receiving the drug and underwent inhalation Methohexitone induction of anaesthesia with halothane and nitrous oxide dose (mg) Surgery time in oxygen. Three of these patients received ten per cent (~n) methohexitone; one received the two per cent solution. 95 -+ 35 minutes for the two and ten per cent methohexitone groups, respectively. The difference was not significant nor were the postanesthesia recovery scores significantly different following surgical procedures of one to four hours duration under halothane and nitrous oxide anaesthesia ( Figure 3 ). In addition to the four patients that did not fall asleep one patient in each group developed hiccoughs during induction. Airway obstruction occurred in two patients that received the two per cent methohexitone solution. In both cases the obstruction was easily relieved by manual support of the airway. Three children from each group exhibited soiling following administration of methohexitone. Two of these three children from each group fell asleep, despite expelling a portion of the administered dose. There were no postoperative complications in either group. The onset of sleep was determined by a non-blinded observer and the possibility of observer bias cannot be excluded. However, Liu et al. reported that peak plasma methohexitonc concentrations occur 14.9 -+ 2.0 minutes following administration of the drug and suggested that a patient is likely to fall asleep, if the peak plasma methohexitone concentration exceeds 2 ~g.ml-tfl In this study plasma methohexitone concentrations at 15 minutes in 25 of the 26 patients that fell asleep exceeded 2 i~g.ml-L Despite use of a non-blinded observer, the clinical findings were consistent with the changes thai occurred in plasma methohexitone concentration and with the reports of other investigators. 3-6'9 Because both solutions resulted in mean plasma methohexitone concentrations exceeding 2 I.~g' ml -~ 15 minutes following drug administration, it is not unexpected that the speed and reliability of induction would be similar for the two selutions. In the four patients who did not lose consciousness methohexitone concentrations remained below 2 ixg. ml -t.
Many factors affect the absorption and bioavailability of rectally administered medication. Because the rectal mucosa consists of a single layer of epithelial cells and does not have villi, the total area for drug absorption is relatively small, Also, venous drainage of the rectum is complex and the site of absorption affects the plasma concentration achieved. Methohexitone absorbed in the upper rectum enters the superior rectal vein and drains through the portal venous system into the liver. In contrast, methohexitone absorbed into the inferior and middle rectal veins enters directly into the systemic circulation. This suggests that first pass hepatic elimination of the drug t4'~5 may be avoided, if it is absorbed in the lower rectum Depositing and retaining methohexitnne in the lower rectum may be difficult. The wall of the lower rectum is sensitive to chemic',d stimulation, also to tonicity and pH, and the defecation reflex is easily stimulated. In addition, muscular activity due to constriction of the anal sphincter may push fluid into the upper rectumJ 6 It has also been suggested that use of a larger volume of a more dilute methohexitonc solution will act as an enema and initiate the defecation reflex, resulting in a higher incidence of soiling. TM Our study does not support this contention. Finally, body position, depth of catheter insertion and the presence of faeces in the rectum may influence the distribution mud absorption of mcthohexitone, although the effect of these factors has not been evaluated. Because of the complex relationship of the elements determining absorption of rectally administered medication, it may be difficult to predict the rate and extent of methohexitone absorption in an individual patient.
Rectal barbiturates can cause pain in humans t and damage to the rectal mucosa in mice. m,ll Hinkle and Weinlander state that the severity of tissue damage seen following rectal methobexitone increased in proportion to the drug-mucosa contact time and the concentration of the methohexitone solution administered." Their findings are consistent with reports of tissue damage following the inadvertent perivascular or intra-arterial injection of other concentrated barbiturate soIutions.~9'2~ Use of a dilute methohexitone solution may minimize the risk of rectal mucosa damage.
In conclusion, we hypothesize that higher plasma levels of methohexitone following the use of the two per cent solution occur because a larger area of rectal mucosa is exposed to the drug, resulting in greater bioavailability. Although both two per cent and ten per cent methohexitone were effective for the induction of anaesthesia, the two per cent solution produced significantly higher plasma methohexitone concentrations. There was no difference in the speed or reliability of induction, the incidence of side effects or the postoperative reCovery between the two groups. Further investigation will be required to determine the optimal dose and concentration of rectal methohexitone for the induction of anaesthesia in children. 
